Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-5364
Fax+1 503-494-3257
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Nagle, MD is an oncologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon.
Education & Training
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2011 - 2014
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2011
Certifications & Licensure
- OR State Medical License 2017 - 2025
Publications & Presentations
PubMed
- 32 citationsImpact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.Jordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, Joshua A Hill, Vicky Wu
Blood. 2022-06-30 - 46 citationsProlonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignanciesSarah J. Nagle, Catherine R. Murphree, Philipp W. Raess, Levanto Schachter, Andy I. Chen
American Journal of Hematology. 2021-04-01 - 41 citationsComorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam Kittai, Ying Huang, Max J. Gordon, Nathan Denlinger, Agrima Mian
Transplantation and Cellular Therapy. 2021-01-01
Press Mentions
- Patients Say Benefits of Brentuximab Vedotin Offset Risk of Peripheral NeuropathyJanuary 31st, 2017